Lack of an association between the TGFBR1*6A variant and colorectal cancer risk

Clinical Cancer Research

Volumn 13, Issue 12, 2007, Pages 3748-3752

  Skoglund, Johanna ^a   Song, Bo ^a,g   Dalén, Johan ^b   Dedorson, Stefan ^h   Edler, David ^c   Hjern, Fredrik ^d   Holm, Jörn ⁱ   Lenander, Claes ^e   Lindforss, Ulrik ^c   Lundqvist, Nils ^j   Olivecrona, Hans ^f   Olsson, Louise ^a   Påhlman, Lars ^k   Rutegård, Jörgen ^l   Smedh, Kennet ^m   Törnqvist, Anders ⁿ   Houlston, Richard S ^o   Lindblom, Annika ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d DANDERYD HOSPITAL   (Sweden)

^e ERSTA HOSPITAL   (Sweden)

^f STOCKHOLM SÖDER HOSPITAL   (Sweden)

^g DALIAN MEDICAL UNIVERSITY   (China)

^h Sodertalje Hospital   (Sweden)

ⁱ GÄVLE HOSPITAL   (Sweden)

^j NORRTÄLJE HOSPITAL   (Sweden)

^k UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^l ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^m CENTRAL HOSPITAL   (Sweden)

ⁿ CENTRAL HOSPITAL   (Sweden)

^o INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ALLELE; ARTICLE; CASE CONTROL STUDY; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; POPULATION; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS;

EID: 34250759902     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2865     Document Type: Article

References (15)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343: 78-85.
3. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
4. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
5. Ebner R, Chen RH, Shum L, et al. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 1993;260:1344-8.
6. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775-85.
7. Pasche B, Kaklamani V, Hou N, et al. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004;22:756-8.
8. Stefanovska AM, Efremov GD, Dimovski AJ, et al. TβR-I(6A) polymorphismis not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. type I TβR-I(6A) is a candidate tumor susceptibility allele. Cancer Res., 58: 2727-32, 1998. Cancer Res 2001;61:8351-2.
9. Samowitz WS, Curtin K, Leppert MF, Slattery ML. Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer. Genes Chromosomes Cancer 2001;32:381-3.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
12. Fleiss JL, Tutyn A, Uray HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980;36: 343-6.
13. Pasche B, Kolachana P, Nafa K, et al. ThR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999;59:5678-82.
14. Spillman MA, Schildkraut JM, Halabi S, et al. Transforming growth factor β receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Gynecol Oncol 2005;97:543-9.
15. Pasche B, Knobloch TJ, Bian Y, et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 2005;294:1634-46.